2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-methyl-3H-purin-6-one structure
|
Common Name | 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-methyl-3H-purin-6-one | ||
|---|---|---|---|---|
| CAS Number | 36799-17-4 | Molecular Weight | 297.27 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C11H15N5O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-methyl-3H-purin-6-one8-Methylguanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-methyl-3H-purin-6-one |
|---|---|
| Synonym | More Synonyms |
| Description | 8-Methylguanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C11H15N5O5 |
|---|---|
| Molecular Weight | 297.27 |
| Exact Mass | 297.10700 |
| PSA | 160.50000 |
| Guanosine,8-methyl |